| Value | ₹180.0 Cr |
|---|---|
| Execution period | ~ 2 years |
BSE filing, NSE: ARTEMISMED. Summary written from the filing by ALFA Finder's alert engine.
Artemis Medicare Services Ltd: key numbers
- Share price
- ₹297.40
- Market cap
- ₹4,708 Cr
- Revenue (annual)
- ₹1,081 Cr
- Net profit (annual)
- ₹103.6 Cr
- P/E (TTM)
- 41.4×Sector 52.0×
- Promoter holding
- 58.39%+0.00% QoQ
- FII holding
- 12.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Artemis Medicare Services Ltd
All →Artemis Medicare Services Board Meeting Date
Artemis Medicare scheduled a board meeting for Oct 30, 2026 to approve Q1 un-audited results. Trading window remains closed until Nov 1, 2026.
Artemis Medicare Services Other Announcement
Artemis Medicare Services Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Artemis Medicare Services Legal & Regulatory
Artemis Medicare received a Rs. 11.11 Crore Show Cause Notice from the GST department. The company is contesting this through a writ petition.
- Value
- ₹11.11 Cr
Artemis Medicare Services Credit Rating
CARE Ratings reaffirmed Artemis Medicare's bank facility ratings at CARE A with Stable outlook. Long-term and short-term facilities totalling ₹388.15 Cr were reviewed.
Artemis Medicare Services Earnings Call Transcript: Key Takeaways
Artemis reports strong Q1 FY27 growth, driven by Gurgaon performance and the Raipur hospital launch. Management is pivoting toward high-end quaternary care with a massive 2,000-bed expansion target by 2030.
Artemis Medicare Services Other Announcement
Artemis Medicare Services filed its Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its past Preferential Issue.
Other capacity expansion announcements
All →Ethos Capacity Expansion
Ethos has opened a new Ethos Summit boutique at Fort, Mumbai, taking its total to 105 boutiques across India. The filing is an update on a store opening with no monetary value disclosed.
- new boutiques
- 1.0 boutiques
Greenply Industries Capacity Expansion
Greenply's board noted a 15 million sq mtr plywood capacity expansion at subsidiary Greenply Sandila, due by Q4 FY2028. Approximately Rs. 125 crore investment is planned.
- Execution
- By Q4 of FY 2028
- plywood manufacturing capacity
- 15.0 million sq mtr
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units
Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment
Senores Pharmaceuticals plans to add 0.8 Bn units of capacity to its existing 1.2 Bn unit plant by March 2027. The investment is Rs.18.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹18.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.8 Bn units
EPack Prefab Technologies Capacity Expansion: ₹100 Cr Investment
EPack Prefab plans to add 11,300 MT of PEB and 8,00,000 sq m of PUF capacity. The ₹100 Crore investment will be funded from IPO proceeds.
- Value
- ₹100.0 Cr
- Execution
- Period stated as 28-10-2026 in the filing (date as filed; the period is not otherwise defined)
- PEB structures capacity addition
- 11300.0 MTPA
EPack Prefab Technologies Capacity Expansion
Epack Prefab added 11,300 MTPA PEB and 8,00,000 sq m PUF capacity from October 28, 2026. The Rs.100 Crore project uses IPO net proceeds.
- PEB structures capacity addition
- 11300.0 MTPA